LARP7's role as a tumour suppressor is attributed to its function as an inhibitor of the positive transcription factor P‐TEFb, a cyclin‐dependent kinase required for RNA polymerase II transcription elongation [Ji et al., 2014; Stavraka and Blagden, 2015]. Here, LARP7 is linked to neoplasm.